Abcam plc (ABCM)

Etorro trading 970x250
Abcam plc (ABCM) Logo

About Abcam plc

Abcam plc, a life sciences company, researches, develops, and distributes biological reagents and tools for research, drug discovery, and diagnostics in the United States, China, Japan, Europe, the Middle East, Africa, and rest of Asia Pacific. The company offers various research products, including primary and secondary antibodies; ELISA and matched antibody pairs; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex assays. Its research products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics, nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. Further, the company offers diagnostic and therapeutic solutions. The company also sells its products online. Abcam plc was founded in 1998 and is headquartered in Cambridge, the United Kingdom. Address: Discovery Drive, Cambridge, United Kingdom, CB2 0AX

Abcam plc News and around…

Latest news about Abcam plc (ABCM) common stock and company :

Abcam completes $340m strategic acquisition and expands kit capacity and capability
27 Oct, 2021 Yahoo! Finance

Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences reagents and tools, today announces the successful completion of its acquisition of BioVision and the expansion of its immunoassay capacity in Eugene, OR.

29% Constant Currency Revenue Growth in H2 as Lab Activity Gradually Recovers and Demand for Abcam In-house Products Increases
13 Sep, 2021 FinancialContent
Earnings Scheduled For September 13, 2021
13 Sep, 2021 FinancialContent

Companies Reporting Before The Bell • Optical Cable (NASDAQ:OCC) is expected to report earnings for its third ...

Abcam To Acquire Supplier BioVision For $340M In Cash
02 Aug, 2021 FinancialContent

Abcam plc(NASDAQ: ABCM)has agreed to acquireBioVision Inc, a wholly-ownedBoai NKY Medical Holdings ...

Abcam to Acquire BioVision for $340 million
02 Aug, 2021 FinancialContent
New Strong Sell Stocks for July 29th
29 Jul, 2021 Yahoo! Finance

ABCM, CCJ, EBMT, MRTN and NESR have been added to the Zacks Rank #5 (Strong Sell) List on July 29, 2021.

Stocks That Hit 52-Week Lows On Tuesday
20 Jul, 2021 FinancialContent

Before 10 a.m. ET Tuesday, 64 stocks made new 52-week lows. Key Facts: TotalEnergies (NYSE:TTE) was the ...

Abcam Enters Oversold Territory (ABCM)
19 Jul, 2021 FinancialContent

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

Is Abcam plc (ABCM) A Smart Long-Term Buy?
13 Jul, 2021 Yahoo! Finance

Headwaters Capital, an investment management firm, published its second quarter 2021 investor letter – a copy of which can be downloaded here. A quarterly portfolio net return of 8.3% was recorded by the fund for the second quarter of 2021, outperforming the Russell Mid Cap Index that delivered a 7.5% return for the same period. […]

Abcam opens new US facility in Boston, MA
13 Jul, 2021 Yahoo! Finance

Abcam (AIM: ABC) (NASDAQ: ABCM), a global innovator in life sciences reagents and tools, today announces the opening of a major new site in Waltham, MA.

Some Shareholders May find It Hard To Increase Abcam plc's (LON:ABC) CEO Compensation This Year
25 Jun, 2021 Yahoo! Finance

The share price of Abcam plc ( LON:ABC ) has struggled to grow by much over the last few years and probably has to do...

Pionyr and Abcam extend partnership to evaluate TREM2-expressing cells in cancer patients
22 Jun, 2021 Yahoo! Finance

Today Pionyr Immunotherapeutics, Inc., a company developing first-in-class antibody therapeutics that increase the body's anti-tumor immunity and Abcam (AIM: ABC) (NASDAQ: ABCM), a global innovator in life science reagents and tools, announced the extension of their collaboration with a new commercial licensing agreement to support the progression of PY314, the first to the clinic of Pionyr's compounds.

2 of the Safest Biotech Stocks You'll Find Today
29 May, 2021 FinancialContent

They provide the infrastructure and sell the tools that biomedical researchers need to make breakthroughs.

Abcam plc (LON:ABC) Insiders Increased Their Holdings
24 May, 2021 Yahoo! Finance

We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be...

Abcam and MEDx extend precision medicine strategic partnership
12 Apr, 2021 FinancialContent
Avacta Announces Distribution Agreement With ABCAM plc
06 Apr, 2021 FinancialContent

Avacta Group plc (AIM: AVCT), the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce that it has entered into a global distribution agreement with ABCAM plc (AIM: ABC; NASDAQ: ABCM) to sell the Group’s recently developed SARS-CoV-2 research ELISA Affimer® reagents.

Abcam Wins Industry Awards from CiteAb
24 Mar, 2021 FinancialContent
Abcam is Now Oversold (ABCM)
08 Mar, 2021 FinancialContent

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

Abcam Plc to Host Earnings Call
08 Mar, 2021 Yahoo! Finance

NEW YORK, NY / ACCESSWIRE / March 8, 2021 / Abcam Plc (NASDAQ:ABCM) will be discussing their earnings results in their 2021 First Half Earnings call to be held on March 8, 2021 at 2:00 PM Eastern Time.To listen to the event live or access a replay of the call - visit https://www.

8.3% constant currency revenue growth in H1 as customers gradually return to labs
08 Mar, 2021 FinancialContent
Abcam Expands Presence in China to Support Increased Demand of BioPharma Sector
04 Mar, 2021 FinancialContent
Abcam to Report Interim Results on Monday, March 8, 2021
26 Feb, 2021 FinancialContent
Abcam to present at the 2021 SVB Leerink Global Healthcare Conference
17 Feb, 2021 FinancialContent
Abingdon Health signs collaboration and co-marketing agreement with Abcam
09 Feb, 2021 FinancialContent
ABCM Crosses Above Average Analyst Target
03 Feb, 2021 FinancialContent

In recent trading, shares of Abcam PLC (ABCM) have crossed above the average analyst 12-month target price of $22.67, changing hands for $22.74/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..

Can You Imagine How Jubilant Abcam's (LON:ABC) Shareholders Feel About Its 164% Share Price Gain?
29 Jan, 2021 Yahoo! Finance

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

Abcam Plc Appointment of Non-Executive Directors
28 Jan, 2021 FinancialContent
Abcam plc Half Year Trading Update
11 Jan, 2021 FinancialContent

Abcam returns to growth in first half with over 8% increase in constant currency revenue

Benzinga's Top Upgrades, Downgrades For November 16, 2020
16 Nov, 2020 FinancialContent

Upgrades For International Paper Co (NYSE: IP), Citigroup upgraded the previous rating of Neutral to the current rating Buy. For ...

Abcam plc: Annual Report, Impact Report and Notice of AGM
03 Nov, 2020 FinancialContent

Abcam plc (ABCM) is a NASDAQ Common Stock listed in , ,

970x250